Immunogenetics of Systemic Sclerosis.

Area of Science:

• Rheumatology and Immunology
• Immunogenetics
• Molecular Biology

Background:

• Systemic sclerosis (SSc) is a rare autoimmune connective tissue disorder.
• Previously viewed as "hyperfibrotic," SSc is now recognized as immune-mediated.
• Genetic research has shifted from fibrotic to immune regulatory pathways.

Purpose of the Study:

• To review key genetic factors influencing systemic sclerosis (SSc) risk and progression.
• To emphasize the role of immune regulatory pathways in SSc pathogenesis.
• To highlight insights from immunogenetics in understanding SSc.

Main Methods:

• Comprehensive literature review of genetic studies in systemic sclerosis.
• Analysis of data linking genetic variations to disease susceptibility and course.
• Focus on immune response regulatory factors.

Main Results:

• Genetic alterations significantly impact SSc risk and progression.
• Certain genetic variations confer protection, while others increase susceptibility.
• Immune regulatory genes are pivotal in SSc pathogenesis.

Conclusions:

• Genetic factors play a crucial role in systemic sclerosis.
• Understanding immunogenetics is key to unraveling SSc pathogenesis.
• Further research into genetic markers may lead to improved SSc management.